FDA Warning Letter — Novoliq, Inc.
The FDA took a Warning Letter action against Novoliq, Inc. on Mar 6, 2019 (Minghang Shanghai, China). The action was issued by CTP and concerns tobacco products.
Action Details
- Facility
- Novoliq, Inc.
- Date
- Mar 6, 2019
- Fiscal Year
- 2019
- Product Type
- Tobacco
- Center
- CTP
- Location
- Minghang Shanghai (China)